Bone marrow adipose tissue explained

Bone marrow adipose tissue
Latin:adipose ossium medulla
System:Musculoskeletal (or locomotor)

Bone marrow adipose tissue (BMAT), sometimes referred to as marrow adipose tissue (MAT), is a type of fat deposit in bone marrow. It increases in states of low bone density -osteoporosis,[1] [2] anorexia nervosa/caloric restriction,[3] [4] skeletal unweighting such as that which occurs in space travel,[5] [6] and anti-diabetes therapies.[7] BMAT decreases in anaemia, leukaemia, and hypertensive heart failure; in response to hormones such as oestrogen, leptin, and growth hormone; with exercise-induced weight loss or bariatric surgery; in response to chronic cold exposure; and in response to pharmacological agents such as bisphosphonates, teriparatide, and metformin.[8]

Anatomy

Bone marrow adipocytes (BMAds)[9] originate from mesenchymal stem cell (MSC) progenitors that also give rise to osteoblasts, among other cell types.[10] Thus, it is thought that BMAT results from preferential MSC differentiation into the adipocyte, rather than osteoblast, lineage in the setting of osteoporosis.[11] Since BMAT is increased in the setting of obesity[12] [13] [14] and is suppressed by endurance exercise,[15] [12] [16] [17] or vibration,[18] it is likely that BMAT physiology, in the setting of mechanical input/exercise, approximates that of white adipose tissue (WAT).

Physiology

Exercise regulation

The first study to demonstrate exercise regulation of BMAT in rodents was published in 2014; Now, exercise regulation of BMAT has been confirmed in a human,[19] adding clinical importance. Several studies demonstrated exercise reduction of BMAT which occurs along with an increase in bone quantity.[20] Since exercise increases bone quantity, reduces BMAT and increases expression of markers of fatty acid oxidation in bone, BMAT is thought to be providing needed fuel for exercise-induced bone formation or anabolism. A notable exception occurs in the setting of caloric restriction: exercise suppression of BMAT does not yield an increase in bone formation and even appears to cause bone loss.[21] Indeed, energy availability appears to be a factor in the ability of exercise to regulate BMAT. Another exception occurs in lipodystrophy, a condition with reduced overall adipose stores: exercise- induced anabolism is possible, even with minimal BMAT stores.[22]

Relationships to other types of fat

BMAT has been reported to have qualities of both white and brown fat.[23] However, more-recent functional and -omics studies have shown that BMAT is a unique adipose depot that is molecularly and functionally distinct to WAT or BAT.[24] [25] [26] [27] Subcutaneous white fat contain excess energy, indicating a clear evolutionary advantage during times of scarcity. WAT is also the source of adipokines and inflammatory markers which have both positive (e.g., adiponectin)[28] and negative[29] effects on metabolic and cardiovascular endpoints. Visceral abdominal fat (VAT) is a distinct type of WAT that is "proportionally associated with negative metabolic and cardiovascular morbidity",[30] regenerates cortisol,[31] and recently has been tied to decreased bone formation[32] [33] Both types of WAT substantially differ from brown adipose tissue (BAT) as by a group of proteins that help BAT's thermogenic role.[34] BMAT, by its "specific marrow location, and its adipocyte origin from at least LepR+ marrow MSC is separated from non-bone fat storage by larger expression of bone transcription factors",[35] and likely indicates a different fat phenotype.[36] Recently, BMAT was noted to "produce a greater proportion of adiponectin – an adipokine associated with improved metabolism – than WAT",[37] suggesting an endocrine function for this depot, akin, but different, from that of WAT.

Impact on bone health

BMAT increases in states of bone fragility. BMAT is thought to result from preferential MSC differentiation into an adipocyte, rather than osteoblast lineage in osteoporosis[11] based on the inverse relationship between bone and BMAT in bone-fragile osteoporotic states. An increase in BMAT is noted in osteoporosis clinical studies measured by MR spectroscopy.[38] [39] [40] Estrogen therapy in postmenopausal osteoporosis reduces BMAT.[41] Antiresorptive therapies like risedronate or zoledronate also decrease BMAT while increasing bone density, supporting an inverse relationship between bone quantity and BMAT. During aging, bone quantity declines[42] [43] and fat redistributes from subcutaneous to ectopic sites such as bone marrow, muscle, and liver.[44] Aging is associated with lower osteogenic and greater adipogenic biasing of MSC.[45] This aging-related biasing of MSC away from osteoblast lineage may represent higher basal PPARγ expression[46] or decreased Wnt10b.[47] [48] [49] Thus, bone fragility, osteoporosis, and osteoporotic fractures are thought to be linked to mechanisms which promote BMAT accumulation.

Maintenance of hematopoietic stem cells

BMAds secrete factors that promote HSC renewal in most bones.[50]

Hematopoietic cells (also known as blood cells) reside in the bone marrow along with BMAds. These hematopoietic cells are derived from hematopoietic stem cells (HSC) which give rise to diverse cells: cells of the blood, immune system, as well as cells that break down bone (osteoclasts). HSC renewal occurs in the marrow stem cell niche, a microenvironment that contains cells and secreted factors that promote appropriate renewal and differentiation of HSC. The study of the stem cell niche is relevant to the field of oncology in order to improve therapy for multiple hematologic cancers. As such cancers are often treated with bone marrow transplantation, there is interest in improving the renewal of HSC.

Measurement

In order to understand the physiology of BMAT, various analytic methods have been applied. BMAds are difficult to isolate and quantify because they are interspersed with bony and hematopoietic elements. Until recently, qualitative measurements of BMAT have relied on bone histology,[51] [52] which is subject to site selection bias and cannot adequately quantify the volume of fat in the marrow. Nevertheless, histological techniques and fixation make possible visualization of BMAT, quantification of BMAd size, and BMAT's association with the surrounding endosteum, milieu of cells, and secreted factors.[53] [54] [55]

Recent advances in cell surface and intracellular marker identification and single-cell analyses led to greater resolution and high-throughput ex-vivo quantification. Flow cytometric quantification can be used to purify adipocytes from the stromal vascular fraction of most fat depots.[56] Early research with such machinery cited adipocytes as too large and fragile for cytometer-based purification, rendering them susceptible to lysis; however, recent advances have been made to mitigate this;[57] nevertheless, this methodology continues to pose technical challenges[58] and is inaccessible to much of the research community.

To improve quantification of BMAT, novel imaging techniques have been developed as a means to visualize and quantify BMAT. Although proton magnetic resonance spectroscopy (1H-MRS) has been used with success to quantify vertebral BMAT in humans,[59] it is difficult to employ in laboratory animals.[60] Magnetic resonance imaging (MRI) provides BMAT assessment in the vertebral skeleton[61] in conjunction with μCT-based marrow density measurements.[62] A volumetric method to identify, quantify, and localize BMAT in rodent bone has been recently developed, requiring osmium staining of bones and μCT imaging,[63] followed by advanced image analysis of osmium-bound lipid volume (in mm3) relative to bone volume. This technique provides reproducible quantification and visualization of BMAT, enabling the ability to consistently quantify changes in BMAT with diet, exercise, and agents that constrain precursor lineage allocation. Although the osmium method is quantitatively precise, osmium is toxic and cannot be compared across batched experiments. Recently, researchers developed and validated a 9.4T MRI scanner technique that allows localization and volumetric (3D) quantification that can be compared across experiments, as in.

Several studies have also analysed BMAT function in vivo using positron emission tomography - computed tomography (PET-CT) combined with the tracer 18F-Fluorodeoxyglucose (FDG). This allows glucose uptake, a measure of metabolic activity, to be quantified in living organisms, including humans. Two recent studies found that, unlike brown adipose tissue, BMAT does not increase glucose uptake in response to cold exposure, demonstrating that BMAT is functionally distinct from BAT.[24] [64] The full extent of BMAT's impact on systemic metabolic homeostasis remains to be determined.

Scientific societies

The International Bone Marrow Adiposity Society (BMAS)

Because of the increasing interest in BMAT from both researchers and clinicians, in 2018 The International Bone Marrow Adiposity Society (BMAS) was founded.[65] Work to build the society began in Lille, France in 2015, when the first International Meeting on Bone Marrow Adiposity (BMA2015) was held. The meeting was a great success and led to a second international meeting (BMA2016) in August 2016 held in Rotterdam, The Netherlands. Both meetings were a success in that they for the first time brought together scientists and physicians from different backgrounds (bone metabolism, cancer, obesity and diabetes) to share ideas and advance research into, and our understanding of, the patho/physiological role of BMAds.

This success led to a network of researchers discussing the formation of a new society, focusing on bone marrow adiposity (BMA). This network worked together in 2016–2017 to lay the foundations for this society, which was then discussed further during the third international meeting held in Lausanne, Switzerland in 2017 (BMA2017). The statues were then signed at the fourth international meeting, held in 2018 again in Lille (BMA2018). As discussed in the following section, there have since been three further international meetings, held in Odense, Denmark in 2019 (BMA2019), virtually in 2020 (BMA2020), and in Athens, Greece in 2022 (BMA2022). The first BMAS Summer School was held virtually in the summer of 2021.

Since its foundation, BMAS working groups have published three position papers relating to nomenclature,[9] methodologies [66] and biobanking for BMA research.[67] These working groups remain active, with other working groups also focussing on clinical and translational issues, public engagement, and young researchers (Next Generation BMAS)

BMAS meetings

American Society for Bone and Mineral Research

ASBMR has published hundreds of presentations and articles on BMAT featured in the ASBMR annual meetings, The Journal of Bone and Mineral Research (JBMR), JBMRPlus, and the Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Endocrine Society

Endocrine society features many presentations and articles on BMAT.

Further reading

Notes and References

  1. Cohen A, Dempster DW, Stein EM, Nickolas TL, Zhou H, McMahon DJ, Müller R, Kohler T, Zwahlen A, Lappe JM, Young P, Recker RR, Shane E . 6 . Increased marrow adiposity in premenopausal women with idiopathic osteoporosis . The Journal of Clinical Endocrinology and Metabolism . 97 . 8 . 2782–2791 . August 2012 . 22701013 . 3410269 . 10.1210/jc.2012-1477 .
  2. Meunier P, Aaron J, Edouard C, Vignon G . Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies . Clinical Orthopaedics and Related Research . 80 . 147–154 . October 1971 . 5133320 . 10.1097/00003086-197110000-00021 .
  3. Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen CJ, Klibanski A . Marrow fat and bone--new perspectives . The Journal of Clinical Endocrinology and Metabolism . 98 . 3 . 935–945 . March 2013 . 23393168 . 3590487 . 10.1210/jc.2012-3634 .
  4. McGrath C, Sankaran JS, Misaghian-Xanthos N, Sen B, Xie Z, Styner MA, Zong X, Rubin J, Styner M . 6 . Exercise Degrades Bone in Caloric Restriction, Despite Suppression of Marrow Adipose Tissue (MAT) . Journal of Bone and Mineral Research . 35 . 1 . 106–115 . January 2020 . 31509274 . 6980282 . 10.1002/jbmr.3872 .
  5. Ahdjoudj S, Lasmoles F, Holy X, Zerath E, Marie PJ . Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma . Journal of Bone and Mineral Research . 17 . 4 . 668–677 . April 2002 . 11918224 . 10.1359/jbmr.2002.17.4.668 . 23060094 . free .
  6. Wronski TJ, Morey ER . Skeletal abnormalities in rats induced by simulated weightlessness . Metabolic Bone Disease & Related Research . 4 . 1 . 69–75 . 1982-01-01 . 7121257 . 10.1016/0221-8747(82)90011-X .
  7. Rubin MR, Manavalan JS, Agarwal S, McMahon DJ, Nino A, Fitzpatrick LA, Bilezikian JP . Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus . The Journal of Clinical Endocrinology and Metabolism . 99 . 10 . E1933–E1942 . October 2014 . 24905061 . 10.1210/jc.2013-3666 . free .
  8. Book: Cawthorn W . Encyclopedia of Bone Biology . Bone Marrow Adipose Tissue . 2020 . Academic Press . Oxford, UK . 978-0-12-814082-6 . 156–177 . 10.1016/B978-0-12-801238-3.11207-3 . 213762507 .
  9. Bravenboer N, Bredella MA, Chauveau C, Corsi A, Douni E, Ferris WF, Riminucci M, Robey PG, Rojas-Sutterlin S, Rosen C, Schulz TJ, Cawthorn WP . 6 . Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society . Frontiers in Endocrinology . 10 . 923 . 2020 . 32038486 . 10.3389/fendo.2019.00923 . 6993042 . free .
  10. Muruganandan S, Roman AA, Sinal CJ . Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program . Cellular and Molecular Life Sciences . 66 . 2 . 236–253 . January 2009 . 18854943 . 10.1007/s00018-008-8429-z . 5558912 . 11131547 .
  11. Paccou J, Hardouin P, Cotten A, Penel G, Cortet B . The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians . The Journal of Clinical Endocrinology and Metabolism . 100 . 10 . 3613–3621 . October 2015 . 26244490 . 10.1210/jc.2015-2338 . free .
  12. Styner M, Thompson WR, Galior K, Uzer G, Wu X, Kadari S, Case N, Xie Z, Sen B, Romaine A, Pagnotti GM, Rubin CT, Styner MA, Horowitz MC, Rubin J . 6 . Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise . Bone . 64 . 39–46 . July 2014 . 24709686 . 4041820 . 10.1016/j.bone.2014.03.044 .
  13. Scheller EL, Khoury B, Moller KL, Wee NK, Khandaker S, Kozloff KM, Abrishami SH, Zamarron BF, Singer K . 6 . Changes in Skeletal Integrity and Marrow Adiposity during High-Fat Diet and after Weight Loss . Frontiers in Endocrinology . 7 . 102 . 2016 . 27512386 . 4961699 . 10.3389/fendo.2016.00102 . free .
  14. Doucette CR, Horowitz MC, Berry R, MacDougald OA, Anunciado-Koza R, Koza RA, Rosen CJ . A High Fat Diet Increases Bone Marrow Adipose Tissue (MAT) But Does Not Alter Trabecular or Cortical Bone Mass in C57BL/6J Mice . Journal of Cellular Physiology . 230 . 9 . 2032–2037 . September 2015 . 25663195 . 4580244 . 10.1002/jcp.24954 .
  15. Styner M, Pagnotti GM, Galior K, Wu X, Thompson WR, Uzer G, Sen B, Xie Z, Horowitz MC, Styner MA, Rubin C, Rubin J . 6 . Exercise Regulation of Marrow Fat in the Setting of PPARγ Agonist Treatment in Female C57BL/6 Mice . Endocrinology . 156 . 8 . 2753–2761 . August 2015 . 26052898 . 4511140 . 10.1210/en.2015-1213 .
  16. Styner M, Pagnotti GM, McGrath C, Wu X, Sen B, Uzer G, Xie Z, Zong X, Styner MA, Rubin CT, Rubin J . 6 . Exercise Decreases Marrow Adipose Tissue Through ß-Oxidation in Obese Running Mice . Journal of Bone and Mineral Research . 32 . 8 . 1692–1702 . August 2017 . 28436105 . 5550355 . 10.1002/jbmr.3159 .
  17. Pagnotti GM, Styner M, Uzer G, Patel VS, Wright LE, Ness KK, Guise TA, Rubin J, Rubin CT . 6 . Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity . Nature Reviews. Endocrinology . 15 . 6 . 339–355 . June 2019 . 30814687 . 6520125 . 10.1038/s41574-019-0170-1 .
  18. Luu YK, Pessin JE, Judex S, Rubin J, Rubin CT . Mechanical Signals As a Non-Invasive Means to Influence Mesenchymal Stem Cell Fate, Promoting Bone and Suppressing the Fat Phenotype . BoneKEy Osteovision . 6 . 4 . 132–149 . April 2009 . 22241295 . 3255555 . 10.1138/20090371 .
  19. Belavy DL, Quittner MJ, Ridgers ND, Shiekh A, Rantalainen T, Trudel G . Specific Modulation of Vertebral Marrow Adipose Tissue by Physical Activity . Journal of Bone and Mineral Research . 33 . 4 . 651–657 . April 2018 . 29336053 . 10.1002/jbmr.3357 . free . 10536/DRO/DU:30106029 . free .
  20. Little-Letsinger SE, Pagnotti GM, McGrath C, Styner M . Exercise and Diet: Uncovering Prospective Mediators of Skeletal Fragility in Bone and Marrow Adipose Tissue . Current Osteoporosis Reports . 18 . 6 . 774–789 . December 2020 . 33068251 . 7736569 . 10.1007/s11914-020-00634-y .
  21. Southmayd EA, Williams NI, Mallinson RJ, De Souza MJ . Energy Deficiency Suppresses Bone Turnover in Exercising Women With Menstrual Disturbances . The Journal of Clinical Endocrinology and Metabolism . 104 . 8 . 3131–3145 . August 2019 . 30896746 . 10.1210/jc.2019-00089 . free .
  22. McGrath C, Little-Letsinger SE, Sankaran JS, Sen B, Xie Z, Styner MA, Zong X, Chen W, Rubin J, Klett EL, Coleman RA, Styner M . 6 . Exercise Increases Bone in SEIPIN Deficient Lipodystrophy, Despite Low Marrow Adiposity . Frontiers in Endocrinology . 12 . 782194 . 2022-01-25 . 35145475 . 8822583 . 10.3389/fendo.2021.782194 . free .
  23. Krings A, Rahman S, Huang S, Lu Y, Czernik PJ, Lecka-Czernik B . Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes . Bone . 50 . 2 . 546–552 . February 2012 . 21723971 . 3214232 . 10.1016/j.bone.2011.06.016 .
  24. Suchacki KJ, Tavares AA, Mattiucci D, Scheller EL, Papanastasiou G, Gray C, Sinton MC, Ramage LE, McDougald WA, Lovdel A, Sulston RJ, Thomas BJ, Nicholson BM, Drake AJ, Alcaide-Corral CJ, Said D, Poloni A, Cinti S, Macpherson GJ, Dweck MR, Andrews JP, Williams MC, Wallace RJ, van Beek EJ, MacDougald OA, Morton NM, Stimson RH, Cawthorn WP . 6 . Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis . Nature Communications . 11 . 1 . 3097 . June 2020 . 32555194 . 10.1038/s41467-020-16878-2 . 7303125 . 2020NatCo..11.3097S .
  25. Craft CS, Robles H, Lorenz MR, Hilker ED, Magee KL, Andersen TL, Cawthorn WP, MacDougald OA, Harris CA, Scheller EL . 6 . Bone marrow adipose tissue does not express UCP1 during development or adrenergic-induced remodeling . Scientific Reports . 9 . 1 . 17427 . November 2019 . 31758074 . 10.1038/s41598-019-54036-x . 6874537 . 2019NatSR...917427C .
  26. Scheller EL, Khandaker S, Learman BS, Cawthorn WP, Anderson LM, Pham HA, Robles H, Wang Z, Li Z, Parlee SD, Simon BR, Mori H, Bree AJ, Craft CS, MacDougald OA . 6 . Bone marrow adipocytes resist lipolysis and remodeling in response to β-adrenergic stimulation . Bone . 118 . 32–41 . January 2019 . 29360620 . 10.1016/j.bone.2018.01.016 . 6062480 .
  27. Attané C, Estève D, Chaoui K, Iacovoni JS, Corre J, Moutahir M, Valet P, Schiltz O, Reina N, Muller C . 6 . Human Bone Marrow Is Adipocytes with Specific Lipid Metabolism . Cell Reports . 30 . 4 . 949–958.e6 . January 2020 . 31995765 . 10.1016/j.celrep.2019.12.089 . 210949460 . free .
  28. Ye R, Scherer PE . Adiponectin, driver or passenger on the road to insulin sensitivity? . Molecular Metabolism . 2 . 3 . 133–141 . April 2013 . 24049728 . 3773837 . 10.1016/j.molmet.2013.04.001 .
  29. Tilg H, Moschen AR . Adipocytokines: mediators linking adipose tissue, inflammation and immunity . Nature Reviews. Immunology . 6 . 10 . 772–783 . October 2006 . 16998510 . 10.1038/nri1937 . 29865593 .
  30. Wronska A, Kmiec Z . Structural and biochemical characteristics of various white adipose tissue depots . Acta Physiologica . 205 . 2 . 194–208 . June 2012 . 22226221 . 10.1111/j.1748-1716.2012.02409.x . 22915022 .
  31. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS . A transgenic model of visceral obesity and the metabolic syndrome . Science . 294 . 5549 . 2166–2170 . December 2001 . 11739957 . 10.1126/science.1066285 . 768303 . 2001Sci...294.2166M .
  32. Bredella MA, Lin E, Gerweck AV, Landa MG, Thomas BJ, Torriani M, Bouxsein ML, Miller KK . 6 . Determinants of bone microarchitecture and mechanical properties in obese men . The Journal of Clinical Endocrinology and Metabolism . 97 . 11 . 4115–4122 . November 2012 . 22933540 . 3485587 . 10.1210/jc.2012-2246 .
  33. Cohen A, Dempster DW, Recker RR, Lappe JM, Zhou H, Zwahlen A, Müller R, Zhao B, Guo X, Lang T, Saeed I, Liu XS, Guo XE, Cremers S, Rosen CJ, Stein EM, Nickolas TL, McMahon DJ, Young P, Shane E . 6 . Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study . The Journal of Clinical Endocrinology and Metabolism . 98 . 6 . 2562–2572 . June 2013 . 23515452 . 3667251 . 10.1210/jc.2013-1047 .
  34. Wu J, Cohen P, Spiegelman BM . Adaptive thermogenesis in adipocytes: is beige the new brown? . Genes & Development . 27 . 3 . 234–250 . February 2013 . 23388824 . 3576510 . 10.1101/gad.211649.112 .
  35. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A . 6 . Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential . Stem Cell Reviews and Reports . 9 . 1 . 32–43 . February 2013 . 22529014 . 3563956 . 10.1007/s12015-012-9365-8 .
  36. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME . Playing with bone and fat . Journal of Cellular Biochemistry . 98 . 2 . 251–266 . May 2006 . 16479589 . 10.1002/jcb.20777 . 19746472 .
  37. Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, Ning X, Bree AJ, Schell B, Broome DT, Soliman SS, DelProposto JL, Lumeng CN, Mitra A, Pandit SV, Gallagher KA, Miller JD, Krishnan V, Hui SK, Bredella MA, Fazeli PK, Klibanski A, Horowitz MC, Rosen CJ, MacDougald OA . 6 . Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction . Cell Metabolism . 20 . 2 . 368–375 . August 2014 . 24998914 . 4126847 . 10.1016/j.cmet.2014.06.003 .
  38. Duque G, Li W, Adams M, Xu S, Phipps R . Effects of risedronate on bone marrow adipocytes in postmenopausal women . Osteoporosis International . 22 . 5 . 1547–1553 . May 2011 . 20661545 . 10.1007/s00198-010-1353-8 . 27850362 .
  39. Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC . Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study . Journal of Magnetic Resonance Imaging . 22 . 2 . 279–285 . August 2005 . 16028245 . 10.1002/jmri.20367 . 2941430 . free .
  40. Li X, Kuo D, Schafer AL, Porzig A, Link TM, Black D, Schwartz AV . Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis . Journal of Magnetic Resonance Imaging . 33 . 4 . 974–979 . April 2011 . 21448966 . 3072841 . 10.1002/jmri.22489 .
  41. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S . Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women . Osteoporosis International . 19 . 9 . 1323–1330 . September 2008 . 18274695 . 2652842 . 10.1007/s00198-008-0574-6 .
  42. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel LJ, Holets M, Peterson JM, Melton LJ . 6 . Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment . Journal of Bone and Mineral Research . 21 . 1 . 124–131 . January 2006 . 16355281 . 1352156 . 10.1359/jbmr.050916 .
  43. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML . Age-related changes in trabecular architecture differ in female and male C57BL/6J mice . Journal of Bone and Mineral Research . 22 . 8 . 1197–1207 . August 2007 . 17488199 . 10.1359/jbmr.070507 . free .
  44. Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD, Kirkland JL . 6 . Fat tissue, aging, and cellular senescence . Aging Cell . 9 . 5 . 667–684 . October 2010 . 20701600 . 2941545 . 10.1111/j.1474-9726.2010.00608.x .
  45. Kassem M, Marie PJ . Senescence-associated intrinsic mechanisms of osteoblast dysfunctions . Aging Cell . 10 . 2 . 191–197 . April 2011 . 21210937 . 10.1111/j.1474-9726.2011.00669.x . free .
  46. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B . Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways . Aging Cell . 3 . 6 . 379–389 . December 2004 . 15569355 . 1850101 . 10.1111/j.1474-9728.2004.00127.x .
  47. Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, Lane TF . Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells . Journal of Bone and Mineral Research . 25 . 10 . 2138–2147 . October 2010 . 20499361 . 3153316 . 10.1002/jbmr.118 .
  48. Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, Lane TF, Krishnan V, Hankenson KD, MacDougald OA . 6 . Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation . Journal of Bone and Mineral Research . 22 . 12 . 1924–1932 . December 2007 . 17708715 . 10.1359/jbmr.070810 . free .
  49. Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q, Cao J, Xie N, Velletri T, Zhang X, Xu C, Zhang L, Yang H, Hou J, Wang Y, Shi Y . 6 . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? . Cell Death and Differentiation . 23 . 7 . 1128–1139 . July 2016 . 26868907 . 4946886 . 10.1038/cdd.2015.168 .
  50. Zhou BO, Yu H, Yue R, Zhao Z, Rios JJ, Naveiras O, Morrison SJ . Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF . Nature Cell Biology . 19 . 8 . 891–903 . August 2017 . 28714970 . 5536858 . 10.1038/ncb3570 .
  51. Bielohuby M, Matsuura M, Herbach N, Kienzle E, Slawik M, Hoeflich A, Bidlingmaier M . Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats . Journal of Bone and Mineral Research . 25 . 2 . 275–284 . February 2010 . 19653818 . 10.1359/jbmr.090813 . free .
  52. Spatz JM, Ellman R, Cloutier AM, Louis L, van Vliet M, Suva LJ, Dwyer D, Stolina M, Ke HZ, Bouxsein ML . 6 . Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading . Journal of Bone and Mineral Research . 28 . 4 . 865–874 . April 2013 . 23109229 . 4076162 . 10.1002/jbmr.1807 .
  53. Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M . 6 . Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program . Bone . 35 . 5 . 1046–1058 . November 2004 . 15542029 . 10.1016/j.bone.2004.07.008 .
  54. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ . Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment . Nature . 460 . 7252 . 259–263 . July 2009 . 19516257 . 2831539 . 10.1038/nature08099 . 2009Natur.460..259N .
  55. David V, Martin A, Lafage-Proust MH, Malaval L, Peyroche S, Jones DB, Vico L, Guignandon A . 6 . Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis . Endocrinology . 148 . 5 . 2553–2562 . May 2007 . 17317771 . 10.1210/en.2006-1704 . free .
  56. Majka SM, Miller HL, Sullivan T, Erickson PF, Kong R, Weiser-Evans M, Nemenoff R, Moldovan R, Morandi SA, Davis JA, Klemm DJ . 6 . Adipose lineage specification of bone marrow-derived myeloid cells . Adipocyte . 1 . 4 . 215–229 . October 2012 . 23700536 . 3609111 . 10.4161/adip.21496 .
  57. Book: Majka SM, Miller HL, Helm KM, Acosta AS, Childs CR, Kong R, Klemm DJ . Analysis and Isolation of Adipocytes by Flow Cytometry . Methods of Adipose Tissue Biology, Part A . 537 . 281–96 . 2014 . 24480352 . 4143162 . 10.1016/b978-0-12-411619-1.00015-x . 9780124116191 . Methods in Enzymology .
  58. Bernstein RL, Hyun WC, Davis JH, Fulwyler MJ, Pershadsingh HA . Flow cytometric analysis of mature adipocytes . Cytometry . 10 . 4 . 469–474 . July 1989 . 2766892 . 10.1002/cyto.990100416 . free .
  59. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Rosen CJ, Klibanski A, Miller KK . 6 . Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women . Obesity . 19 . 1 . 49–53 . January 2011 . 20467419 . 3593350 . 10.1038/oby.2010.106 .
  60. de Paula FJ, Dick-de-Paula I, Bornstein S, Rostama B, Le P, Lotinun S, Baron R, Rosen CJ . 6 . VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner . Calcified Tissue International . 89 . 3 . 179–191 . September 2011 . 21637996 . 3157554 . 10.1007/s00223-011-9505-1 .
  61. Fazeli PK, Bredella MA, Freedman L, Thomas BJ, Breggia A, Meenaghan E, Rosen CJ, Klibanski A . 6 . Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa . Journal of Bone and Mineral Research . 27 . 9 . 1864–1871 . September 2012 . 22508185 . 3415584 . 10.1002/jbmr.1640 .
  62. Rantalainen T, Nikander R, Heinonen A, Cervinka T, Sievänen H, Daly RM . Differential effects of exercise on tibial shaft marrow density in young female athletes . The Journal of Clinical Endocrinology and Metabolism . 98 . 5 . 2037–2044 . May 2013 . 23616150 . 10.1210/jc.2012-3748 . free . 10536/DRO/DU:30060423 . free .
  63. Book: Scheller EL, Troiano N, Vanhoutan JN, Bouxsein MA, Fretz JA, Xi Y, Nelson T, Katz G, Berry R, Church CD, Doucette CR, Rodeheffer MS, Macdougald OA, Rosen CJ, Horowitz MC . Use of Osmium Tetroxide Staining with Microcomputerized Tomography to Visualize and Quantify Bone Marrow Adipose Tissue in Vivo . Methods of Adipose Tissue Biology, Part A . 6 . 537 . 123–39 . 2014 . 24480344 . 4097010 . 10.1016/b978-0-12-411619-1.00007-0 . 9780124116191 . Methods in Enzymology .
  64. Pham TT, Ivaska KK, Hannukainen JC, Virtanen KA, Lidell ME, Enerbäck S, Mäkelä K, Parkkola R, Piirola S, Oikonen V, Nuutila P, Kiviranta R . 6 . Human Bone Marrow Adipose Tissue is a Metabolically Active and Insulin-Sensitive Distinct Fat Depot . The Journal of Clinical Endocrinology and Metabolism . 105 . 7 . 2300–2310 . July 2020 . 32311037 . 10.1210/clinem/dgaa216 . 7247553 .
  65. Web site: The International Bone Marrow Adiposity Society . BMAS Website.
  66. Tratwal J, Labella R, Bravenboer N, Kerckhofs G, Douni E, Scheller EL, Badr S, Karampinos DC, Beck-Cormier S, Palmisano B, Poloni A, Moreno-Aliaga MJ, Fretz J, Rodeheffer MS, Boroumand P, Rosen CJ, Horowitz MC, van der Eerden BC, Veldhuis-Vlug AG, Naveiras O . 6 . Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society . Frontiers in Endocrinology . 11 . 65 . 2020 . 32180758 . 10.3389/fendo.2020.00065 . 7059536 . free .
  67. Lucas S, Tencerova M, von der Weid B, Andersen TL, Attané C, Behler-Janbeck F, Cawthorn WP, Ivaska KK, Naveiras O, Podgorski I, Reagan MR, van der Eerden BC . 6 . Guidelines for Biobanking of Bone Marrow Adipose Tissue and Related Cell Types: Report of the Biobanking Working Group of the International Bone Marrow Adiposity Society . Frontiers in Endocrinology . 12 . 744527 . 2021 . 34646237 . 10.3389/fendo.2021.744527 . 8503265 . free .
  68. Hardouin P, Marie PJ, Rosen CJ . New insights into bone marrow adipocytes: Report from the First European Meeting on Bone Marrow Adiposity (BMA 2015) . Bone . 93 . 212–215 . December 2016 . 26608519 . 10.1016/j.bone.2015.11.013 .
  69. van der Eerden B, van Wijnen A . Meeting report of the 2016 bone marrow adiposity meeting . Adipocyte . 6 . 4 . 304–313 . October 2017 . 28410005 . 10.1080/21623945.2017.1313374 . 5736244 .
  70. Corsi A, Palmisano B, Tratwal J, Riminucci M, Naveiras O . Brief Report From the 3rd International Meeting on Bone Marrow Adiposity (BMA 2017) . Frontiers in Endocrinology . 10 . 336 . 2019 . 31191458 . 6546805 . 10.3389/fendo.2019.00336 . free .
  71. Penel G, Kerckhofs G, Chauveau C . Brief Report From the 4th International Meeting on Bone Marrow Adiposity (BMA2018) . Frontiers in Endocrinology . 10 . 691 . 2019 . 31681168 . 10.3389/fendo.2019.00691 . 6813723 . free .
  72. Scheller EL, McGee-Lawrence ME, Lecka-Czernik B . Report From the 6th International Meeting on Bone Marrow Adiposity (BMA2020) . Frontiers in Endocrinology . 12 . 712088 . 2021 . 34335478 . 10.3389/fendo.2021.712088 . 8323480 . free .
  73. Labella R, Little-Letsinger S, Avilkina V, Sarkis R, Tencerova M, Vlug A, Palmisano B . Next Generation Bone Marrow Adiposity Researchers: Report From the 1st BMAS Summer School 2021 . Frontiers in Endocrinology . 13 . 879588 . 2022 . 35498418 . 10.3389/fendo.2022.879588 . 9043644 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bone marrow adipose tissue".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.